Latest article
Provention Bio Offers Extra Regulatory Replace on Biologics License Software for Teplizumab for the...
RED BANK, NJ, April 27, 2021 / PRNewswire / - Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company devoted to catching and preventing immune-mediated...
American Diabetes Affiliation, with Visionary Companions VSP Imaginative and prescient Care and Regeneron Launch...
To mark May's Healthy Vision Month, Focus on Diabetes ™ was launched - a multi-year initiative bringing together the American Diabetes Association® (ADA) and...
